Exact Mass: 300.1725354
Exact Mass Matches: 300.1725354
Found 500 metabolites which its exact mass value is equals to given mass value 300.1725354,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Methoxyestrone
2-Methoxyestrone (or 2-ME1) belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, 2-methoxyestrone is considered to be a steroid or steroid derivative. It is a by-product of estrone and 2-hydroxyestrone metabolism and has been detected in all mammals. More specifically, 2-methoxyestrone is an endogenous, naturally occurring methoxylated catechol estrogen and a metabolite of estrone that is formed by catechol O-methyltransferase via the intermediate 2-hydroxyestrone. 2-Methoxyestrone is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone has been determined to be 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17). Unlike estrone but similarly to 2-hydroxyestrone and 2-methoxyestradiol, 2-methoxyestrone has very low affinity for the estrogen receptor and lacks significant estrogenic activity (PMID: 10865186). 2-methoxyestrone is a steroid derivative that is a byproduct of estrone and 2-hydroxyestrone metabolism. It is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone is 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-Methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-Methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17). [HMDB] C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 2-Methoxyestrone is a methoxylated catechol estrogen and metabolite of estrone, with a pKa of 10.81.
Adrenosterone
Adrenosterone is a steroid hormone with weak androgenic effect. It was first isolated in 1936 from the adrenal cortex by Tadeus Reichstein at the Pharmaceutical Institute in the University of Basel. Originally, adrenosterone was called Reichsteins substance G.(Wikipedia). Andrenosterone is created from androst-4-ene-3,17-dione by the work of two enzymes, CYP11B (E1.14.15.4) and 11beta-hydroxysteroid dehydrogenase [EC:1.1.1.146]. Adrenosterone is a steroid hormone with weak androgenic effect. It was first isolated in 1936 from the adrenal cortex by Tadeus Reichstein at the Pharmaceutical Institute in the University of Basel. Originally, adrenosterone was called Reichsteins substance G. Adrenosterone ((+)-Adrenosterone) is a competitive hydroxysteroid (11-beta) dehydrogenase 1 (HSD11β1) inhibitor. Adrenosterone is a steroid hormone with weak androgenic effect. Adrenosterone is a dietary supplement that can decrease fat and increase muscle mass. Adrenosterone acts as a suppressor of metastatic progression of human cancer cells[1][2][3].
Testolactone
Testolactone is only found in individuals that have used or taken this drug. It is an antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer. [PubChem]Although the precise mechanism by which testolactone produces its clinical antineoplastic effects has not been established, its principal action is reported to be inhibition of steroid aromatase activity and consequent reduction in estrone synthesis from adrenal androstenedione, the major source of estrogen in postmenopausal women. Based on in vitro studies, the aromatase inhibition may be noncompetitive and irreversible. This phenomenon may account for the persistence of testolactones effect on estrogen synthesis after drug withdrawal. C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents
19-Oxoandrost-4-ene-3,17-dione
19-Oxoandrost-4-ene-3,17-dione is an intermediate in Androgen and estrogen metabolism. 19-Oxoandrost-4-ene-3,17-dione is the 4th to last step in the synthesis of 2-Methoxyestrone 3-glucuronide. It is generated from 19-Hydroxyandrost-4-ene-3,17-dione and then converted to Estrone. [HMDB] 19-Oxoandrost-4-ene-3,17-dione is an intermediate in Androgen and estrogen metabolism. 19-Oxoandrost-4-ene-3,17-dione is the 4th to last step in the synthesis of 2-Methoxyestrone 3-glucuronide. It is generated from 19-Hydroxyandrost-4-ene-3,17-dione and then converted to Estrone. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Prallethrin
D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins
Bifenazate
Bifenazate is a carbazate acaricide that control 100\% of mites at a concentration of 25 ppm[1]. Bifenazate is a positive allosteric modulator of GABA receptor[2].
Sageone
Sageone is a diterpenoid. Sageone is a natural product found in Salvia pachyphylla, Salvia, and other organisms with data available. Constituent of Salvia officinalis (sage). Sageone is found in tea, herbs and spices, and common sage. Sageone is found in common sage. Sageone is a constituent of Salvia officinalis (sage).
Ginsenoyne F
Ginsenoyne F is found in tea. Ginsenoyne F is isolated from ginseng. Isolated from ginseng. Ginsenoyne F is found in tea.
2-Hydroxy-3-methoxyestrone
2-Hydroxy-3-methoxyestrone is obtained after methylation of 2-Hydroxyestrone and is generally found in the urine as an excretion product. 2-hydroxyestrone is the result of the hydroxylation of estrone E1. The hydroxylation process helps to clear out E1 from the body. This is critical because higher lifetime exposure to estrogen has been found to increase cancer risks to the reproductive system, especially to the breast. However, 2-hydroxyestrone has a weak estrogenic activity and breast cancer risks are quite low in women with high urinary excretion of 2-hydroxyestrone. 2-Hydroxy-3-methoxyestrone levels in urine could be an indicator to help assess the risk factors for development of breast cancers. DG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
4-Methoxyestrone
Thyrotropin-releasing hormone (TRH), also called thyrotropin-releasing factor (TRF), thyroliberin or protirelin, is a tripeptide hormone that stimulates the release of thyroid-stimulating hormone and prolactin by the anterior pituitary. In humans, it also acts as a prolactin-releasing factor. It is also a neurotransmitter in the central nervous system. TRH is produced by the hypothalamus and travels across the median eminence to the pituitary via the hypophyseal portal system. In addition to the brain, TRH can also be detected in other areas of the body including the gastrointestinal system and pancreatic islets. Medical preparations of TRH are used in diagnostic tests of thyroid disorders and in acromegaly. [HMDB] This compound belongs to the family of Ketosteroids. These are steroid derivatives comprising a ketone group attached to steroid skeleton.
Androst-4-ene-3,6,17-trione
Azapropazone
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents
(8S,9R,10R,13S,14S)-10,13-Dimethyl-4,5,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11,17-trione
5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N'-propylpentanehydrazide
19-oxoandrostenedione
19-oxoandrostenedione belongs to androgens and derivatives class of compounds. Those are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. 19-oxoandrostenedione is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). 19-oxoandrostenedione can be found in a number of food items such as cassava, pepper (spice), durian, and common salsify, which makes 19-oxoandrostenedione a potential biomarker for the consumption of these food products.
2-trans,-6-trans-farnesyl monophosphate
2-trans,-6-trans-farnesyl monophosphate, also known as (2e,6e)-farnesyl phosphate or (2e,6e)-farnesol monophosphoric acid(2-), is a member of the class of compounds known as sesquiterpenoids. Sesquiterpenoids are terpenes with three consecutive isoprene units. 2-trans,-6-trans-farnesyl monophosphate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). 2-trans,-6-trans-farnesyl monophosphate can be found in a number of food items such as opium poppy, papaya, pepper (c. frutescens), and corn, which makes 2-trans,-6-trans-farnesyl monophosphate a potential biomarker for the consumption of these food products.
odorine
C18H24N2O2 (300.18376839999996)
Odorine is a natural product found in Aglaia elliptica, Aglaia odorata, and Aglaia argentea with data available.
3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]prop-2-enoic acid
2-(1,5-Heptadienyl)-3,6-dihydroxy-5-(3-methyl-2-butenyl)benzaldehyde
2-(2,3-Epoxy-1-heptenyl)-6-hydroxy-5-(3-methyl-2-butenyl)benzaldehyde
(3R,5R)-1-(4-Hydroxyphenyl)-7-phenyl-3,5-heptanediol
Acetyl-Gln-Leu-amide
CASMI2013 Challenge_3 MS2 data; [MS1] MSJ00005 CASMI2013 Challenge_3 MS1 data; [MS2] MSJ00006
(5E)-2-heptyl-3,4,7-trihydroxy-2,3,4,7,8,9-hexahydrooxecin-10-one
(2Z,4E)-3-methyl-5-(1,2,4-trihydroxy-2-hydroxymethyl-6,6-dimethylcyclohexyl)penta-2,4-dienoic acid|monaspilosuslin
debenzoyl-7-deoxo-1alpha,7alpha-dihydroxytashironin
Miltipolone
Miltipolone is a natural product found in Salvia miltiorrhiza with data available.
2-hydroxyandrosta-1,4-diene-3,16-dione|trichiliasterone B
8-Ac-(Z)-1,9,16-Heptadecatriene-4,6-diyne-3,8-diol|Dehydro-falcarindiol-8-acetat
1-Ac-(E,E,E)-2,8,10-Heptadecatriene-4,6-diyne-1,14-diol|17-acetoxy-heptadeca-7t,9t,15t-triene-11,13-diyn-4-ol|all-trans-1-Acetoxy-heptadecatrien-(2.8.10)-diin-(4.6)-ol-(14)|O1-acetyl-enanthotoxin|O1-acetyl-oenanthotoxin
14-angeloyloxy-tetradeca-5c,10t,12t-trien-8-yn-1-al
12alpha-12-Hydroxyandrosta-1,4-diene-3,17-dione|12alpha-hydroxyandrosta-1,4-dien-3,17-dione
(+)-(8S,8R)-4,4-dihydroxy-3-methoxylignan
A lignan that is 2,3-dimethylbutane substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a 4-hydroxyphenyl group at position 4 respectively. It has been isolated from the bark of Machilus robusta.
(2Z,10E)-9-hydroxyheptadeca-2,10,16-triene-4,6-diynyl acetate|asterynes B
3,5-bis-(3,3-dimethylallyl)-p-coumaric acid|3,5-bis-<3,3-dimethylallyl>-p-coumaric acid
(2E,6S)-3-methyl-6-hydroxy-6-[(2R,5R)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl]-hex-2-enoaic acid methyl ester
7-acetoxy-2-acetyl-1,1-dimethyl-2,3,4,9-tetrahydro-1H-beta-carboline
6-Hydroxy-4,5-didehydro-5,6-secoenryopsin-2-methylacrylat
3,5-Dihydroxy-5-heptyl-2,3,3a,5,5a,8-hexahydro-6H-1,4,7-trioxacyclopenta[c]pentalene-6-one
9alpha,11alpha,15S-Trihydroxy-2,3,4,5-tetra-nor-13-prostensaeure
2-hepta-1,5-dienyl-3,6-dihydroxy-5-(3-methylbut-2-enyl)benzaldehyde
1-Ac-(8E,15Z)-2,9,16-Heptadecatriene-4,6-diyne-1,11-diol
19-nor-3-hydroxyspongia-3,13(16),14-trien-2-one|3-Hydroxy-19-nor-3,13(16)-,14-spongiatrien-2-one
2-Pentyl-5-hydroxy-6-prenylbenzofuran-4-carbaldehyde
2-Hydroxy-oestron-3-methylether|2-Hydroxyestron-3-methylaether|2-Hydroxyestron-3-methylether
ent-15,16-epoxy-2-hydroxy-19-norbeyer-1,4-dien-3-one
Hydroxylupanine HCl
Tetracaine hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol
(5E)-2-heptyl-3,4,7-trihydroxy-2,3,4,7,8,9-hexahydrooxecin-10-one
2-Methoxyestrone
A 17-oxo steroid that is estrone in which the hydrogen at position 2 has been replaced by a methoxy group. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 2-Methoxyestrone is a methoxylated catechol estrogen and metabolite of estrone, with a pKa of 10.81.
Adrenosterone
A 3-oxo Delta(4)-steroid that is androst-4-ene carrying three oxo-substituents at positions 3, 11 and 17. Adrenosterone ((+)-Adrenosterone) is a competitive hydroxysteroid (11-beta) dehydrogenase 1 (HSD11β1) inhibitor. Adrenosterone is a steroid hormone with weak androgenic effect. Adrenosterone is a dietary supplement that can decrease fat and increase muscle mass. Adrenosterone acts as a suppressor of metastatic progression of human cancer cells[1][2][3].
1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol
Testolactone
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents SubCategory_DNP: : The sterols, Androstanes
(5E)-2-heptyl-3,4,7-trihydroxy-2,3,4,7,8,9-hexahydrooxecin-10-one_major
1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol_major
(5E)-2-heptyl-3,4,7-trihydroxy-2,3,4,7,8,9-hexahydrooxecin-10-one_minor
(5E)-2-heptyl-3,4,7-trihydroxy-2,3,4,7,8,9-hexahydrooxecin-10-one_5.9\\%
Ala Pro Gly Gly
Gly Ala Gly Pro
Gly Ala Pro Gly
Gly Gly Ala Pro
Gly Gly Pro Ala
Gly Pro Gly Ala
Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-
C18H24N2O2 (300.18376839999996)
5a,7a-Dihydroxy-11-ketotetranorprostanoic acid
methyl (E)-2-methyl-4-((3aS)-1-methyl-5-oxo-2,3,5,8a-tetrahydropyrrolo[2,3-b]indol-3a(1H)-yl)but-2-enoate
13,14-dihydro-15-keto-tetranor PGF1&beta
Zinndiol: 1-[4,5-Bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methyl-2,3-butanediol
ST 19:4;O3
An androstanoid that is androst-4-en-19-al substituted by oxo groups at positions 3 and 17. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen 2-Methoxyestrone is a methoxylated catechol estrogen and metabolite of estrone, with a pKa of 10.81.
Teslac
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents
(2-methyl-5-prop-2-ynyl-3-furyl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate
butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enoic acid
2-Hydroxymethyl-piperazine-1,4-dicarboxylic acid 4-allyl ester 1-tert-butyl ester
4-[6-(4-aminophenoxy)hexoxy]aniline
C18H24N2O2 (300.18376839999996)
[2-(2-methyl-3-nitro-phenyl)-ethyl]-dipropyl-amine hydrochloride
trimethyl-[2-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethynyl]silane
3-[1,1-Biphenyl]-4-yl-1,2,3,4-tetrahydro-1-naphthol
3-PHENYL-1-(PYRIDIN-2-YL)-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA[C]PYRIDINE
4-(4-phenylphenyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine
(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione
1-Benzyl-2-amino-3-tert-butoxycarbonyl-4,5-dimethylpyrrole
C18H24N2O2 (300.18376839999996)
ETHYL 3-(TERT-BUTYL)-1-(3-METHYLBENZYL)-1H-PYRAZOLE-5-CARBOXYLATE
C18H24N2O2 (300.18376839999996)
:(S)-2-Methyl-3-(2-propynyl)-4-oxocyclopent-2-enyl-(lR)-cis,trans-2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate
4-(1H-Indol-1-yl)-1-Piperidinecarboxylic Acid Tert-Butyl Ester
C18H24N2O2 (300.18376839999996)
tert-butyl 4-(1H-indol-3-yl)piperidine-1-carboxylate
C18H24N2O2 (300.18376839999996)
Pirbuterol Acetate
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
Pirnabine
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
4-ACETYLAMINO-2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXOAMMONIUM TETRAFLUOROBORATE
1-BOC-4-CYANO-4-(2-METHYLPHENYL)-PIPERIDINE
C18H24N2O2 (300.18376839999996)
methyl 4-[(2-butyl-5-formylimidazol-1-yl)methyl]benzoate
4-(4-Cyano-benzyl)-piperidine-1-carboxylic acid tert-butyl ester
C18H24N2O2 (300.18376839999996)
3-(TERT-BUTYL)-1-(MESITYLMETHYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID
C18H24N2O2 (300.18376839999996)
trimethyl-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethynyl]silane
3-[2-(Trimethylsilyl)ethynyl]benzeneboronic acid pinacol ester
Benzoic acid,2-hydroxy-, compd. with 3-[(2S)-1-methyl-2-pyrrolidinyl]pyridine (1:1)
2,2-[[4-[(4-aminophenyl)azo]phenyl]imino]bisethanol
Itasetron
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
17beta-Hydroxy-3-methoxyestra-1,3,5(10)-trien-16-one
Estra-1,3,5(10)-trien-17-one, 2-hydroxy-3-methoxy-
4-[(4-Ethyl-1-piperazinyl)methyl]-5,7-dimethyl-1-benzopyran-2-one
C18H24N2O2 (300.18376839999996)
9,11-Epoxyandrost-4-ene-3,17-dione, (9beta,11beta)-
2-[2-(1H-Imidazol-1-yl)ethyl]-2,5,7,8-tetramethylchroman-6-ol
C18H24N2O2 (300.18376839999996)
3-Amino-4-{3-[2-(2-propoxy-ethoxy)-ethoxy]-propylamino}-cyclobut-3-ene-1,2-dione
Azapropazone
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents
(8S,9R,10R,13S,14S)-10,13-Dimethyl-4,5,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11,17-trione
10a,12a-Dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-4bH-1-oxa-chrysene-2,8-dione
(S)-N-methylcoclaurinium(1+)
The conjugate acid of (S)-N-methylcoclaurine; major species at pH 7.3.
Codeine(1+)
The conjugate acid of codeine arising from protonation of the tertiary amino group; major species at pH 7.3.
(2S)-2-[[(2S)-2-[[(E)-4-amino-4-oxobut-2-enoyl]amino]-3-azaniumylpropanoyl]amino]-3-methylbutanoate
(8R,9S,13R,14S)-3-hydroxy-4-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-propylpentanehydrazide
[3-Carboxy-2-[3-(carboxymethyl)-2-methylidenebut-3-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(2Z,5E)-3-hydroxyocta-2,5-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(2Z,6E)-3-hydroxyocta-2,6-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(3Z,6E)-3-hydroxyocta-3,6-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(2Z,4E)-3-hydroxyocta-2,4-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,6E)-3-hydroxyocta-4,6-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(3Z,5E)-3-hydroxyocta-3,5-dienoyl]oxypropyl]-trimethylazanium
4-benzoyl-2-heptyl-5-methyl-4H-pyrazol-3-one
C18H24N2O2 (300.18376839999996)
13,14-dihydro-15-keto-tetranor Prostaglandin F1beta
5-(4-ethoxyphenyl)-N-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1,3,4-oxadiazol-2-amine
N-methyl-N-[(E)-(2,4,5-trimethoxyphenyl)methylideneamino]aniline
6-De(cyclopropylamino)-6-(2-methylazetidin-1-yl)abacavir
(5R,8R)-8-methyl-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(7S)-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
[(1R,2aS,8bS)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-cyclohexylmethanone
C18H24N2O2 (300.18376839999996)
[(1S,2aS,8bS)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-cyclohexylmethanone
C18H24N2O2 (300.18376839999996)
(4R,7S)-4-methyl-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(4R,7R)-4-methyl-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(5S)-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(7R)-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
[(1S,2aR,8bR)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-cyclohexylmethanone
C18H24N2O2 (300.18376839999996)
[(1R,2aR,8bR)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-cyclohexylmethanone
C18H24N2O2 (300.18376839999996)
1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidinium(1+)
(1S,7R,8R,14S)-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),12(19)-diene-6,9-dione
C18H24N2O2 (300.18376839999996)
N-[2-(3,4-dimethoxyphenyl)ethyl]-7H-purin-1-ium-6-amine
1,1,3,3-Tetramethyl-1,2,3,4-tetrahydro-gamma-carboline-5-propionic acid
C18H24N2O2 (300.18376839999996)
2-[Hydroxy-(2-hydroxy-3-propoxypropoxy)phosphoryl]oxyethyl-trimethylazanium
3-Hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione
(1R,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptane-2beta-ol 3-(4-hydroxyphenyl)acrylate
(2E,6E)-farnesyl monophosphate(2-)
An organophosphate oxoanion that is the dianion obtained by removal of the two protons from the monophosphate group of (2E,6E)-farnesyl monophosphate. Major species at pH 7.3.
dapdiamide A zwitterion
A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of dapdiamide A; major species at pH 7.3.
4-Methoxyestrone
A 17-oxo steroid that is estrone in which the hydrogen at position 4 has been replaced by a methoxy group. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
methyl 8R,9R-epoxy-13Z,15Z-eicosadien-4,6-diynoate
neopine(1+)
An ammonium ion derivative that is the conjugate acid of neopine arising from protonation of the tertiary amino group; major species at pH 7.3.
BIA 10-2474
BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.
(4bs)-3-hydroxy-2-isopropyl-4b,8,8-trimethyl-6,7-dihydro-5h-fluorene-1,4-dione
(6r)-6-[(1s,4s)-1,4-dihydroxy-4-methylcyclohex-2-en-1-yl]-6-hydroxyheptan-2-yl acetate
2-(hepta-1,5-dien-1-yl)-3,6-dihydroxy-5-(3-methylbut-2-en-1-yl)benzaldehyde
(2s)-2-{[(2s)-3-amino-1-hydroxy-2-{[(2e)-1-hydroxy-3-(c-hydroxycarbonimidoyl)prop-2-en-1-ylidene]amino}propylidene]amino}-3-methylbutanoic acid
15-hydroxy-5-methoxy-6,12,12-trimethyltricyclo[9.4.0.0³,⁸]pentadeca-1,3(8),4,6-tetraen-9-one
4-[4-(4-hydroxyphenyl)-2,3-dimethylbutyl]-3-methoxyphenol
8-[(2r,3s)-3-(hept-6-en-1-yl)oxiran-2-yl]oct-1-en-4,6-diyn-3-yl acetate
2-[(1e,5e)-hepta-1,5-dien-1-yl]-3,6-dihydroxy-5-(3-methylbut-2-en-1-yl)benzaldehyde
(2r)-2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-hydroxy-4-methyl-1-benzofuran-3-one
(2e)-1-{2-hydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl}-3-(4-hydroxyphenyl)prop-2-en-1-one
5-(tetradeca-5,8,11,13-tetraen-1-yn-1-yloxy)pent-4-enoic acid
(2's,3s)-2-hydroxy-2'-(3-oxopentyl)spiro[indole-3,3'-pyrrolidine]-1'-carbaldehyde
(4r,5e,7s,8s,10s)-10-heptyl-4,7,8-trihydroxy-3,4,7,8,9,10-hexahydrooxecin-2-one
(3as,5r,5as,7r,8s,9r,9as,9br)-5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol
(3r,4s,5r)-3-hydroxy-8-oxo-1,7-dioxaspiro[4.4]nonan-4-yl octanoate
1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecane-2,8,13,14-tetrol
(3r,5r)-1-(4-hydroxyphenyl)-7-phenylheptane-3,5-diol
(1r,2r,9r,12s,16r)-5-acetyl-1,12-dimethyl-10-oxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-5,7-dien-11-one
n-{4-[(1-hydroxy-3-phenylprop-2-en-1-ylidene)amino]butyl}-2-methylbut-2-enimidic acid
C18H24N2O2 (300.18376839999996)
(3s,4'r)-4',5,6,6-tetramethyl-8,9-dihydro-7h-spiro[naphtho[1,2-c]furan-3,2'-oxolan]-1-one
14-hydroxyheptadeca-2,8,10-trien-4,6-diyn-1-yl acetate
(1r,3r,4r,5r,6r,7s,11r)-3,4,6-trihydroxy-5-(hydroxymethyl)-4,5,11-trimethyl-8-oxatricyclo[5.3.2.0¹,⁶]dodecan-9-one
(4e)-5-[(5e,8e,11e)-tetradeca-5,8,11,13-tetraen-1-yn-1-yloxy]pent-4-enoic acid
5-hydroxy-6-(3-methylbut-2-en-1-yl)-2-pentyl-1-benzofuran-4-carbaldehyde
ethyl (2r)-2,5-bis[(2s)-butan-2-yl]-3-hydroxy-6-oxo-1,3,4-oxadiazine-2-carboxylate
(3as,3br,5s,9ar,9bs,11as)-5-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-dione
2,8,10-heptadecatriene-4,6-diyne-1,14-diol; (2z,8e,10e,14ξ)-form,14-ac
{"Ingredient_id": "HBIN005042","Ingredient_name": "2,8,10-heptadecatriene-4,6-diyne-1,14-diol; (2z,8e,10e,14\u03be)-form,14-ac","Alias": "NA","Ingredient_formula": "C19H24O3","Ingredient_Smile": "NA","Ingredient_weight": "300.39","OB_score": "NA","CAS_id": "111128-30-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8803","PubChem_id": "NA","DrugBank_id": "NA"}
2-bornanol; (1r,2s)-form,o-(4-hydroxycinnamoyl)(e-)
{"Ingredient_id": "HBIN005410","Ingredient_name": "2-bornanol; (1r,2s)-form,o-(4-hydroxycinnamoyl)(e-)","Alias": "NA","Ingredient_formula": "C19H24O3","Ingredient_Smile": "NA","Ingredient_weight": "300.39","OB_score": "NA","CAS_id": "56711-21-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8684","PubChem_id": "NA","DrugBank_id": "NA"}
(3r,5r)-1-(4-hydroxyphenyl)-7-phenyl-3,5-heptanediol
{"Ingredient_id": "HBIN009538","Ingredient_name": "(3r,5r)-1-(4-hydroxyphenyl)-7-phenyl-3,5-heptanediol","Alias": "NA","Ingredient_formula": "C19H24O3","Ingredient_Smile": "C1=CC=C(C=C1)CCC(CC(CCC2=CC=C(C=C2)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10629","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-methylcryptoacetalide
{"Ingredient_id": "HBIN012559","Ingredient_name": "6-methylcryptoacetalide","Alias": "NA","Ingredient_formula": "C19H24O3","Ingredient_Smile": "CC1CC2(C3=C(C4=C(C(=C3)C)C(CCC4)(C)C)C(=O)O2)OC1","Ingredient_weight": "300.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14255","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5319566","DrugBank_id": "NA"}
acetyl-bupleurotoxin
{"Ingredient_id": "HBIN014461","Ingredient_name": "acetyl-bupleurotoxin","Alias": "NA","Ingredient_formula": "C19H24O3","Ingredient_Smile": "CCCC(CCC=CC=CC#CC#CC=CCO)OC(=O)C","Ingredient_weight": "300.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "340","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "6435768","DrugBank_id": "NA"}
(1s,3r,9r,10r,13s)-3,7-dihydroxy-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadeca-4,7,14-trien-6-one
2-(3,7-dimethylocta-2,6-dien-1-yl)-2-hydroxy-4-methyl-1-benzofuran-3-one
10-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-dione
(2r,3r)-2,3-dihydroxy-3-(5-oxo-2h-furan-3-yl)propyl octanoate
(3r,4'r)-4',5,6,6-tetramethyl-8,9-dihydro-7h-spiro[naphtho[1,2-c]furan-3,2'-oxolan]-1-one
3,4b,8,8-tetramethyl-10-oxo-6,7,8a,9-tetrahydro-5h-phenanthrene-2-carboxylic acid
3a-hydroxy-9a,11a-dimethyl-2h,3h,3bh,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-dione
3,7-dimethylocta-2,6-dien-1-yl 3-(4-hydroxyphenyl)prop-2-enoate
8-hydroxy-9a,11a-dimethyl-1h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione
(2e)-3-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxyphenyl}prop-2-enoic acid
3,7-dihydroxy-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadeca-4,7,14-trien-6-one
2-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]butanimidic acid
C18H24N2O2 (300.18376839999996)
3-[4-hydroxy-2,6-bis(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
2-(hepta-1,3-dien-1-yl)-3,6-dihydroxy-5-(3-methylbut-2-en-1-yl)benzaldehyde
(1r,2s)-2-ethenyl-2,6-dimethyl-1h,3h,4h,7h-cyclohexa[c]carbazole-1-carbonitrile
(1r,9s,11s)-4-hydroxy-6,12,12-trimethyl-17-oxatetracyclo[7.6.2.0¹,¹¹.0²,⁸]heptadeca-2(8),3,6-trien-5-one
n'-{5-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]naphthalen-1-yl}-n,n-dimethylcarbamimidic acid
(1r,3r,4s,7s,8s,9r,11s,12s)-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecane-3,11,12-triol
(4bs,7s,8as)-7-ethenyl-3-hydroxy-4b,7-dimethyl-5,6,8,8a,9,10-hexahydrophenanthrene-1-carboxylic acid
(1s,3s,9r,10r,13s)-3,7-dihydroxy-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadeca-4,7,14-trien-6-one
(3s,8s,9z)-3-hydroxyheptadeca-1,9,16-trien-4,6-diyn-8-yl acetate
(1r,3s,12r)-6-methoxy-7,13,13-trimethyl-2-oxatetracyclo[10.4.0.0¹,³.0⁴,⁹]hexadeca-4(9),5,7-trien-10-one
(1s,9r,10s,13s,14r,16s)-7-hydroxy-5,9,13-trimethyl-15-oxapentacyclo[11.3.1.0¹,¹⁰.0⁴,⁹.0¹⁴,¹⁶]heptadeca-4,7-dien-6-one
5-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-dione
(3s,8s,9e)-3-hydroxyheptadeca-1,9,16-trien-4,6-diyn-8-yl acetate
1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl 3-(4-hydroxyphenyl)prop-2-enoate
(8e,10e,14s)-14-hydroxyheptadeca-2,8,10-trien-4,6-diyn-1-yl acetate
(1s,2r,5r,6s,8r,10s,13r,14r)-1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecane-2,8,13,14-tetrol
2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-hydroxy-4-methyl-1-benzofuran-3-one
4-[(5s)-5-hydroxy-7-(4-hydroxyphenyl)heptyl]phenol
(2s)-1-[4,5-bis(hydroxymethyl)-3-methoxy-2-methylphenoxy]-3-methylbutane-2,3-diol
7-ethenyl-3-hydroxy-4b,7-dimethyl-5,6,8,8a,9,10-hexahydrophenanthrene-1-carboxylic acid
(1s,4as,5r,6s,7r,8ar)-6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid
(3as,3bs,9ar,9bs,10r,11as)-10-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-dione
7-[4-(dimethylamino)phenyl]-n,4,6-trimethyl-7-oxohepta-2,4-dienimidic acid
C18H24N2O2 (300.18376839999996)
(3br,5ar,9ar,9br)-7-hydroxy-3b,6,9a-trimethyl-4h,5h,5ah,9h,9bh,10h,11h-phenanthro[1,2-c]furan-8-one
(1r,2r,4s,5r,6r,12r,13r)-4,5,12,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecan-9-one
7-hydroxy-13-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadeca-4,7,14-trien-6-one
(1r,4as,10ar)-7-acetyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid
3-[4-hydroxy-2,5-bis(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
(2e)-3-[4-hydroxy-2,5-bis(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
(1r,2s,5r,6s,7s,8r,11r)-11-[(2r)-1,2-dihydroxypropan-2-yl]-7-hydroxy-5-(hydroxymethyl)-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecan-10-one
7-heptyl-4,7-dihydroxy-2,6,10-trioxatricyclo[6.3.0.0¹,⁵]undecan-9-one
7-hydroxy-5,9,13-trimethyl-15-oxapentacyclo[11.3.1.0¹,¹⁰.0⁴,⁹.0¹⁴,¹⁶]heptadeca-4,7-dien-6-one
(2r)-2-hydroxy-2-[(1r)-4-methylcyclohex-3-en-1-yl]propyl (2e)-3-phenylprop-2-enoate
1-(dimethylamino)-13-ethenyl-5-hydroxy-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraene-11-carboxylic acid
5-acetyl-1,12-dimethyl-10-oxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-5,7-dien-11-one
(1s)-1-{4-methoxy-3-[(1e)-3-methylbuta-1,3-dien-1-yl]phenyl}ethyl 3-methylbut-2-enoate
(2e,8s,9z)-8-hydroxyheptadeca-2,9,16-trien-4,6-diyn-1-yl acetate
(7s,8r,9s,10r)-9-[2-(furan-3-yl)ethyl]-9,10-dimethyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3-dien-7-ol
(1s,4as,10ar)-7-acetyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid
7-acetyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid
(1r,2s,4r)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(3ar,5s,5ar,7s,8r,9s,9ar,9bs)-5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol
(2r)-2-methyl-n-[(2s)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]butanimidic acid
C18H24N2O2 (300.18376839999996)
(2e,8e,10e,14s)-14-hydroxyheptadeca-2,8,10-trien-4,6-diyn-1-yl acetate
ethyl (6r)-3,6-bis[(2s)-butan-2-yl]-5-hydroxy-4-oxo-1,2,5-oxadiazine-6-carboxylate
(2s)-4-(acetyloxy)-2-[(2s,3r)-2,3-dimethyl-5-oxooxolan-2-yl]-2-methylbutyl acetate
(4bs)-1-hydroxy-2-isopropyl-4b,8,8-trimethyl-6,7-dihydro-5h-fluorene-3,4-dione
(1r,3r,4s,7s,8s,9r,11s,12r)-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecane-3,11,12-triol
(1r,2r,4s,5r,6r,7r,8r)-4,5,7-trihydroxy-6-(hydroxymethyl)-2,6,7-trimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-10-one
(4bs,8as)-3,4b,8,8-tetramethyl-10-oxo-6,7,8a,9-tetrahydro-5h-phenanthrene-2-carboxylic acid
4-methyl-9-methylidene-14-(penta-3,4-dien-1-ylidene)-5,12-dioxatricyclo[8.4.0.0⁴,⁶]tetradecan-13-one
11-hydroxyheptadeca-2,9,16-trien-4,6-diyn-1-yl acetate
1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(3s,8s)-3-hydroxyheptadeca-1,9,16-trien-4,6-diyn-8-yl acetate
(10s,11r,14r,16r)-5,11,14-trimethyl-2,7-dioxapentacyclo[8.8.0.0¹,³.0⁴,⁸.0¹¹,¹⁶]octadeca-4,8-dien-6-one
(2s)-2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-hydroxy-4-methyl-1-benzofuran-3-one
4-[(2s,3r)-4-(4-hydroxyphenyl)-2,3-dimethylbutyl]-3-methoxyphenol
(1s,4ar,5r,6s,7r,8ar)-6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid
(1r,9s,11r)-4-hydroxy-6,12,12-trimethyl-17-oxatetracyclo[7.6.2.0¹,¹¹.0²,⁸]heptadeca-2(8),3,6-trien-5-one
2,10-dihydroxy-6,6-dimethyl-5-methylidene-9-oxoundecyl acetate
3-hydroxyheptadeca-1,9,16-trien-4,6-diyn-8-yl acetate
4,5,7-trihydroxy-6-(hydroxymethyl)-2,6,7-trimethyl-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-10-one
7-acetyl-6-hydroxy-1,1,4a-trimethyl-3,4,10,10a-tetrahydro-2h-phenanthren-9-one
4-[(5r)-5-hydroxy-7-(4-hydroxyphenyl)heptyl]phenol
(2e)-3-[4-hydroxy-2,6-bis(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
(3s)-4',5,6,6-tetramethyl-8,9-dihydro-7h-spiro[naphtho[1,2-c]furan-3,2'-oxolan]-1-one
(1s,2r,4s)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(2e)-n-(4-{[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]amino}butyl)-2-methylbut-2-enimidic acid
C18H24N2O2 (300.18376839999996)
5,8-dimethyl-1-methylidene-octahydronaphtho[2,1-b]furan-3a,7,8,9,9b-pentol
2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecane-2,5,9,11,13-pentol
(2r)-2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]butanimidic acid
C18H24N2O2 (300.18376839999996)
(2e,4e,6s)-7-[4-(dimethylamino)phenyl]-n,4,6-trimethyl-7-oxohepta-2,4-dienimidic acid
C18H24N2O2 (300.18376839999996)
2-[(3e,5e)-hepta-3,5-dien-1-yl]-3,6-dihydroxy-5-(3-methylbut-2-en-1-yl)benzaldehyde
4-(acetyloxy)-2-[(2s,3r)-2,3-dimethyl-5-oxooxolan-2-yl]-2-methylbutyl acetate
(4r,7e,9e,15z)-17-hydroxyheptadeca-7,9,15-trien-11,13-diyn-4-yl acetate
ethyl (6s)-3,6-bis[(2s)-butan-2-yl]-5-hydroxy-4-oxo-1,2,5-oxadiazine-6-carboxylate
(3s)-8-[(2r,3s)-3-(hept-6-en-1-yl)oxiran-2-yl]oct-1-en-4,6-diyn-3-yl acetate
(1r,2r,4r)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(1s,4s,6s,10r,14z)-4-methyl-9-methylidene-14-(penta-3,4-dien-1-ylidene)-5,12-dioxatricyclo[8.4.0.0⁴,⁶]tetradecan-13-one
6,7-dihydroxy-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1,5-dicarboxylic acid
(3s,4's)-4',5,6,6-tetramethyl-8,9-dihydro-7h-spiro[naphtho[1,2-c]furan-3,2'-oxolan]-1-one
(2e,4e)-7-[4-(dimethylamino)phenyl]-n,4,6-trimethyl-7-oxohepta-2,4-dienimidic acid
C18H24N2O2 (300.18376839999996)
3,4,6-trihydroxy-5-(hydroxymethyl)-4,5,11-trimethyl-8-oxatricyclo[5.3.2.0¹,⁶]dodecan-9-one
(2r,3s,4s,5s)-2-[(3e,5s)-5-hydroxy-4,8-dimethylnona-3,7-dien-1-yl]oxane-3,4,5-triol
(3as,3bs,9as,9bs,11ar)-8-hydroxy-9a,11a-dimethyl-1h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione
(2z,8e,10e,14s)-14-hydroxyheptadeca-2,8,10-trien-4,6-diyn-1-yl acetate
{4,5-dimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,4,7-tetraen-6-ylidene}(methyl)oxidanium
(1r,4r,5s,7r,8s)-7-heptyl-4,7-dihydroxy-2,6,10-trioxatricyclo[6.3.0.0¹,⁵]undecan-9-one
(3as,3br,9ar,9bs,11as)-3a-hydroxy-9a,11a-dimethyl-2h,3h,3bh,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-dione
2-acetyl-1,1-dimethyl-3h,4h,9h-pyrido[3,4-b]indol-7-yl acetate
2-ethenyl-2,6-dimethyl-1h,3h,4h,7h-cyclohexa[c]carbazole-1-carbonitrile
10-heptyl-4,7,8-trihydroxy-3,4,7,8,9,10-hexahydrooxecin-2-one
ethyl (2s)-2,5-bis[(2s)-butan-2-yl]-3-hydroxy-6-oxo-1,3,4-oxadiazine-2-carboxylate
(1r,9r,13r)-1-(dimethylamino)-13-ethenyl-5-hydroxy-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraene-11-carboxylic acid
6-(1,4-dihydroxy-4-methylcyclohex-2-en-1-yl)-6-hydroxyheptan-2-yl acetate
4',5,6,6-tetramethyl-8,9-dihydro-7h-spiro[naphtho[1,2-c]furan-3,2'-oxolan]-1-one
(1r,2s,3s,5r,6r,7s,10s,11r)-6-hydroxy-7,11-dimethyl-4-oxapentacyclo[8.8.0.0²,⁷.0³,⁵.0¹¹,¹⁶]octadeca-15,17-dien-14-one
4-hydroxy-6,12,12-trimethyl-17-oxatetracyclo[7.6.2.0¹,¹¹.0²,⁸]heptadeca-2(8),3,6-trien-5-one
7-hydroxy-3b,6,9a-trimethyl-4h,5h,5ah,9h,9bh,10h,11h-phenanthro[1,2-c]furan-8-one
(7e,9e,15z)-17-hydroxyheptadeca-7,9,15-trien-11,13-diyn-4-yl acetate
n,n'-bis[(4-methoxyphenyl)methyl]carbamimidic acid
3-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]butanimidic acid
C18H24N2O2 (300.18376839999996)
4,5,12,13-tetrahydroxy-2,6,13-trimethyl-8-oxatricyclo[4.4.3.0¹,⁵]tridecan-9-one
9-[2-(furan-3-yl)ethyl]-9,10-dimethyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3-dien-7-ol
(11r,15r)-15-hydroxy-5-methoxy-6,12,12-trimethyltricyclo[9.4.0.0³,⁸]pentadeca-1,3(8),4,6-tetraen-9-one
ethyl 3-hydroxy-6-oxo-2,5-bis(sec-butyl)-1,3,4-oxadiazine-2-carboxylate
3-methyl-n-{1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl}butanimidic acid
C18H24N2O2 (300.18376839999996)
6-methoxy-7,13,13-trimethyl-2-oxatetracyclo[10.4.0.0¹,³.0⁴,⁹]hexadeca-4(9),5,7-trien-10-one
(4e)-5-[(5e,8e,11z)-tetradeca-5,8,11,13-tetraen-1-yn-1-yloxy]pent-4-enoic acid
(11r,15s)-15-hydroxy-5-methoxy-6,12,12-trimethyltricyclo[9.4.0.0³,⁸]pentadeca-1,3(8),4,6-tetraen-9-one
(2s)-2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]butanimidic acid
C18H24N2O2 (300.18376839999996)
2-(hepta-3,5-dien-1-yl)-3,6-dihydroxy-5-(3-methylbut-2-en-1-yl)benzaldehyde
(1s,2r,4s)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate
ethyl 5-hydroxy-4-oxo-3,6-bis(sec-butyl)-1,2,5-oxadiazine-6-carboxylate
(4s,4as,5s)-3,4a,5-trimethyl-4-(2-methylpropanoyl)-4h,5h,6h,7h-naphtho[2,3-b]furan-9-one
3-[3-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxyphenyl]prop-2-enoic acid
14-oxotetradeca-2,4,9-trien-6-yn-1-yl 2-methylbut-2-enoate
(1r,9r,10r,13r)-7-hydroxy-13-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadeca-4,7,14-trien-6-one
(1r,2s,5s,6s,9s,10s,11s,13r)-2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecane-2,5,9,11,13-pentol
(2e,4e,9z)-14-oxotetradeca-2,4,9-trien-6-yn-1-yl (2z)-2-methylbut-2-enoate
1-[4-methoxy-3-(3-methylbuta-1,3-dien-1-yl)phenyl]ethyl 3-methylbut-2-enoate
(5s,6e,8s,9s,10r)-10-heptyl-5,8,9-trihydroxy-3,4,5,8,9,10-hexahydrooxecin-2-one
(4r,7e,9e)-17-hydroxyheptadeca-7,9,15-trien-11,13-diyn-4-yl acetate
2-hydroxy-2-(4-methylcyclohex-3-en-1-yl)propyl 3-phenylprop-2-enoate
3-hydroxy-2-isopropyl-4b,8,8-trimethyl-6,7-dihydro-5h-fluorene-1,4-dione
(2z,9e,11r)-11-hydroxyheptadeca-2,9,16-trien-4,6-diyn-1-yl acetate
(1r,2s,6r,7r,8s,9r,11s,12r)-1,4,4-trimethyl-10,14-dioxatetracyclo[9.2.1.0²,⁶.0⁸,¹²]tetradecane-7,8,9,12-tetrol
3,4a,5-trimethyl-4-(2-methylpropanoyl)-4h,5h,6h,7h-naphtho[2,3-b]furan-9-one
(3s,8s,9z)-8-hydroxyheptadeca-1,9,16-trien-4,6-diyn-3-yl acetate
(2e)-3,7-dimethylocta-2,6-dien-1-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
3-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]butanimidic acid
C18H24N2O2 (300.18376839999996)